FoI Number
2023-215
Subject
Treatments
Date Received
11/07/2023
Request and Response
  1. In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]:

Berinert (Human C1-esterase inhibitor) 

Cinryze (Human C1-esterase inhibitor) 

Orladeyo (berotralstat)

Takhzyro (Lanadelumab) 

Ruconest (Recombinant human C1-esterase inhibitor) 

Firazyr (Icatibant) 

Icatibant – any brand except Firazyr

 

NHS Shetland do not stock any of these medicines and have had no requests for use.